Literature DB >> 22421228

Natural history of coronary atherosclerosis by multislice computed tomography.

Stella-Lida Papadopoulou1, Lisan A Neefjes, Hector M Garcia-Garcia, Willem-Jan Flu, Alexia Rossi, Anoeshka S Dharampal, Pieter H Kitslaar, Nico R Mollet, Susan Veldhof, Koen Nieman, Gregg W Stone, Patrick W Serruys, Gabriel P Krestin, Pim J de Feyter.   

Abstract

OBJECTIVES: This study sought to analyze the natural history of coronary atherosclerosis by multislice computed tomography (MSCT) and assess the serial changes in coronary plaque burden, lumen dimensions, and arterial remodeling.
BACKGROUND: MSCT can comprehensively assess coronary atherosclerosis by combining lumen and plaque size parameters.
METHODS: Thirty-two patients with acute coronary syndromes underwent 64-slice computed tomography angiography after percutaneous coronary intervention at baseline and after a median of 39 months. All patients received contemporary medical treatment. All available coronary segments in every subject were analyzed. The progression of atherosclerosis per segment and per patient was assessed by means of change in percent atheroma volume (PAV), change in normalized total atheroma volume (TAVnorm), and percent change in TAV (% change in TAV). Serial coronary remodeling was also assessed. Measures of lumen stenosis included percent diameter stenosis (%DS), minimum lumen diameter (MLD), percent area stenosis (%AS), and minimum lumen area (MLA). For each patient, the mean of all matched segments was calculated at the 2 time points. Clinical events at follow-up were documented.
RESULTS: The PAV did not change significantly (-0.15 ± 3.64%, p = 0.72). The mean change in TAVnorm was 47.36 ± 143.24 mm(3) (p = 0.071), and the % change in TAV was 6.7% (p = 0.029). The MLD and MLA increased by 0.15 mm (-0.09 to 0.24, p = 0.039) and 0.52 mm(2) (-0.38 to 1.04, p = 0.034) respectively, which was accompanied by vessel enlargement, with 53% of the patients showing expansive positive remodeling. Patients with clinical events had a larger TAVnorm at baseline (969.72 mm(3) vs. 810.77 mm(3), p = 0.010).
CONCLUSIONS: MSCT can assess the progression of coronary atherosclerosis and may be used for noninvasive monitoring of pharmacological interventions in coronary artery disease. ( PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions; NCT00180466).
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22421228     DOI: 10.1016/j.jcmg.2012.01.009

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  38 in total

1.  Multicenter AIDS Cohort Study Quantitative Coronary Plaque Progression Study: rationale and design.

Authors:  Rine Nakanishi; Wendy S Post; Kazuhiro Osawa; Eranthi Jayawardena; Michael Kim; Nasim Sheidaee; Negin Nezarat; Sina Rahmani; Nicholas Kim; Nicolai Hathiramani; Shriraj Susarla; Frank Palella; Mallory Witt; Michael J Blaha; Todd T Brown; Lawrence Kingsley; Sabina A Haberlen; Christopher Dailing; Matthew J Budoff
Journal:  Coron Artery Dis       Date:  2018-01       Impact factor: 1.439

2.  Relationship of left ventricular mass to coronary atherosclerosis and myocardial ischaemia: the CORE320 multicenter study.

Authors:  Satoru Kishi; Tiago A Magalhaes; Richard T George; Marc Dewey; Roger J Laham; Hiroyuki Niinuma; Lisa Aronson Friedman; Christopher Cox; Yutaka Tanami; Joanne D Schuijf; Andrea L Vavere; Kakuya Kitagawa; Marcus Y Chen; Cesar H Nomura; Jeffrey A Brinker; Frank J Rybicki; Marcelo F Di Carli; Armin Arbab-Zadeh; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-11-02       Impact factor: 6.875

3.  Optimal boundary detection method and window settings for coronary atherosclerotic plaque volume analysis in coronary computed tomography angiography: comparison with intravascular ultrasound.

Authors:  Ran Heo; Hyung-Bok Park; Byoung Kwon Lee; Sanghoon Shin; Reza Arsanjani; James K Min; Hyuk-Jae Chang
Journal:  Eur Radiol       Date:  2015-12-02       Impact factor: 5.315

Review 4.  Emerging Role of Coronary Computed Tomography Angiography in Lipid-Lowering Therapy: a Bridge to Image-Guided Personalized Medicine.

Authors:  Toru Miyoshi; Kazuhiro Osawa; Keishi Ichikawa; Kazuki Suruga; Takashi Miki; Masashi Yoshida; Koji Nakagawa; Hironobu Toda; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Ito
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

5.  Coronary Atherosclerotic Precursors of Acute Coronary Syndromes.

Authors:  Hyuk-Jae Chang; Fay Y Lin; Sang-Eun Lee; Daniele Andreini; Jeroen Bax; Filippo Cademartiri; Kavitha Chinnaiyan; Benjamin J W Chow; Edoardo Conte; Ricardo C Cury; Gudrun Feuchtner; Martin Hadamitzky; Yong-Jin Kim; Jonathon Leipsic; Erica Maffei; Hugo Marques; Fabian Plank; Gianluca Pontone; Gilbert L Raff; Alexander R van Rosendael; Todd C Villines; Harald G Weirich; Subhi J Al'Aref; Lohendran Baskaran; Iksung Cho; Ibrahim Danad; Donghee Han; Ran Heo; Ji Hyun Lee; Asim Rivzi; Wijnand J Stuijfzand; Heidi Gransar; Yao Lu; Ji Min Sung; Hyung-Bok Park; Daniel S Berman; Matthew J Budoff; Habib Samady; Leslee J Shaw; Peter H Stone; Renu Virmani; Jagat Narula; James K Min
Journal:  J Am Coll Cardiol       Date:  2018-06-05       Impact factor: 24.094

Review 6.  Noninvasive Imaging of Atherosclerotic Plaque Progression: Status of Coronary Computed Tomography Angiography.

Authors:  Veit Sandfort; Joao A C Lima; David A Bluemke
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

Review 7.  Comprehensive plaque assessment by coronary CT angiography.

Authors:  Pál Maurovich-Horvat; Maros Ferencik; Szilard Voros; Béla Merkely; Udo Hoffmann
Journal:  Nat Rev Cardiol       Date:  2014-04-22       Impact factor: 32.419

8.  Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression.

Authors:  Kazuhiro Osawa; Rine Nakanishi; Theingi Tiffany Win; Dong Li; Sina Rahmani; Negin Nezarat; Nasim Sheidaee; Matthew J Budoff
Journal:  Clin Cardiol       Date:  2017-07-13       Impact factor: 2.882

9.  Relative atherosclerotic plaque volume by CT coronary angiography trumps conventional stenosis assessment for identifying flow-limiting lesions.

Authors:  Nahoko Kato; Satoru Kishi; Armin Arbab-Zadeh; Frank J Rybicki; Shuzou Tanimoto; Jiro Aoki; Mika Watanabe; Yu Horiuchi; Koichi Furui; Kazuhiro Hara; Kenji Ibukuro; Joao A C Lima; Kengo Tanabe
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-08       Impact factor: 2.357

Review 10.  Plaque assessment by coronary CT.

Authors:  Bálint Szilveszter; Csilla Celeng; Pál Maurovich-Horvat
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-18       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.